Results 201 to 210 of about 2,326,033 (267)

Developable surfaces

openaire   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Transcriptome profiling of ocular surface ectoderm derived from embryonic stem cells, and identification of CACNG6 and AQP3 as its surface markers. [PDF]

Int J Ophthalmol
Sun L, Li YM, Song YW, Yang YC, Duan L, Gao Y, Li JX, Yu YK, Pang KP, Dang GF, Zhang CW.   +10 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Development of a New Bioadhesive Gel in the Prevention of Bacterial Biofilms on Dental Implants: An In Vitro Study. [PDF]

Clin Exp Dent Res
Baus-Domínguez M, Hermida-Cabrera P, Pascual J, Vivancos-Cuadras F, Serrera-Figallo MÁ, Gutiérrez-Pérez JL, Torres-Lagares D.   +6 more
europepmc   +1 more source

Plastic Shrinkage Cracking of Full-Scale Concrete Slabs Under Field-Production Conditions: Observations on Mix Design, Environmental Exposure and Curing. [PDF]

Materials (Basel)
Rutkowska G, Francke B, Żółtowski M, Ostrzyżek E.   +3 more
europepmc   +1 more source

Should we return to probability distributions to represent interfacial reactivity? [PDF]

Nat Commun
Criscenti LJ.
europepmc   +1 more source